Christina Große-Thie

Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial

Volker Kunzmann, Jens T. Siveke, Hana Algül et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 184 citations

Pancreatic Cancer, Gastrointestinal Oncology, Medicine +9

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial

Dietrich W. Beelen, Rudolf Trenschel, Matthias Stelljes et al. · The Lancet Haematology · 2019 · 147 citations · Full text

Longitudinal observation of anxiety and depression among palliative care cancer patients

Corinna Sewtz, Wiebke Muscheites, Christina Große-Thie et al. · Annals of Palliative Medicine · 2021 · 62 citations · Full text

AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial

Stephanie Sasse, Paul J. Bröckelmann, Jesko Momotow et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2022 · 52 citations

A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)

Johanna Inhestern, Harald Schmalenberg, Andreas Dietz et al. · Annals of Oncology · 2017 · 43 citations · Full text

Surgical Oncology, Postoperative Radiotherapy, Medicine +8